Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Susan H Alexander. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Susan H Alexander har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BIIB / Biogen Inc. | EVP Chief Legal Officer | 36 265 |
US:IVC / Invacare Corp. | Director | 104 499 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Susan H Alexander. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Susan H Alexander som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-12 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −807 | 36 265 | −2,18 | 142,54 | −115 030 | 5 169 213 | |
2025-02-12 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 575 | 37 072 | 7,46 | ||||
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −591 | 34 497 | −1,68 | 141,35 | −83 538 | 4 876 151 | |
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 940 | 35 088 | 5,85 | ||||
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −643 | 33 148 | −1,90 | 141,35 | −90 888 | 4 685 470 | |
2025-02-10 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 190 | 33 791 | 6,93 | ||||
2024-11-07 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
G - Gift | 20 082 | 20 082 | |||||
2024-11-07 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
G - Gift | −20 082 | 31 601 | −38,86 | ||||
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −781 | 51 683 | −1,49 | 219,08 | −171 101 | 11 322 712 | |
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 614 | 52 464 | 3,17 | ||||
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 656 | 50 850 | −3,15 | 219,08 | −362 796 | 11 140 218 | |
2024-02-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 3 423 | 52 506 | 6,97 | ||||
2024-02-13 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −938 | 49 083 | −1,88 | 240,98 | −226 039 | 11 828 021 | |
2024-02-13 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 575 | 50 021 | 5,43 | ||||
2024-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −655 | 47 446 | −1,36 | 240,30 | −157 396 | 11 401 274 | |
2024-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 190 | 48 101 | 4,77 | ||||
2023-02-22 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −929 | 45 911 | −1,98 | 278,38 | −258 615 | 12 780 704 | |
2023-02-22 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 920 | 46 840 | 4,27 | ||||
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −2 737 | 44 920 | −5,74 | 286,30 | −783 603 | 12 860 596 | |
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −701 | 47 657 | −1,45 | 286,30 | −200 696 | 13 644 199 | |
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 448 | 48 358 | 3,09 | ||||
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −764 | 46 910 | −1,60 | 286,30 | −218 733 | 13 430 333 | |
2023-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 575 | 47 674 | 5,71 | ||||
2023-01-27 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
A - Award | 5 703 | 45 099 | 14,48 | ||||
2022-10-28 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
S - Sale | X | −5 532 | 39 396 | −12,31 | 280,70 | −1 552 832 | 11 058 457 |
2022-04-05 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 39 474 | 104 499 | 60,71 | ||||
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −2 137 | 7 248 | −22,77 | ||||
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 485 | 9 385 | −13,66 | ||||
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −659 | 44 928 | −1,45 | 209,79 | −138 252 | 9 425 445 | |
2022-02-23 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 485 | 45 587 | 3,37 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −2 090 | 3 218 | −39,37 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 126 | 5 308 | −17,50 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −2 190 | 0 | −100,00 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 154 | 2 190 | −34,51 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 044 | 44 102 | −2,31 | 214,59 | −224 032 | 9 463 848 | |
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −500 | 45 146 | −1,10 | 214,59 | −107 295 | 9 687 880 | |
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 126 | 45 646 | 2,53 | ||||
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −512 | 44 520 | −1,14 | 214,59 | −109 870 | 9 553 547 | |
2022-02-15 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 154 | 45 032 | 2,63 | ||||
2022-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 7 725 | 7 725 | |||||
2022-01-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
A - Award | 2 825 | 43 878 | 6,88 | ||||
2022-01-21 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
G - Gift | −523 | 41 053 | −1,26 | ||||
2021-03-16 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 13 388 | 65 025 | 25,93 | ||||
2021-02-22 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 10 870 | 10 870 | |||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 367 | 6 434 | −17,52 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 849 | 7 801 | −19,16 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 402 | 3 344 | −29,54 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 936 | 4 746 | −28,97 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 788 | 0 | −100,00 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 586 | 1 788 | −47,01 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −607 | 41 576 | −1,44 | 278,03 | −168 764 | 11 559 375 | |
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −622 | 42 183 | −1,45 | 278,03 | −172 935 | 11 728 139 | |
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −704 | 42 805 | −1,62 | 278,03 | −195 733 | 11 901 074 | |
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 367 | 43 509 | 3,24 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 402 | 42 142 | 3,44 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 586 | 40 740 | 4,05 | ||||
2021-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 963 | 39 154 | −4,77 | 278,03 | −545 773 | 10 885 987 | |
2021-01-29 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
A - Award | 4 545 | 41 117 | 12,43 | ||||
2020-03-31 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 15 439 | 51 637 | 42,65 | ||||
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 171 | 0 | −100,00 | ||||
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 553 | 1 171 | −57,01 | ||||
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −689 | 36 572 | −1,85 | 333,00 | −229 437 | 12 178 476 | |
2020-02-19 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 553 | 37 261 | 4,35 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 803 | 6 682 | −21,25 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 535 | 8 485 | −15,32 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 697 | 0 | −100,00 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 633 | 3 374 | −32,61 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 735 | 5 007 | −25,73 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 9 650 | 9 650 | |||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −681 | 35 708 | −1,87 | 331,76 | −225 929 | 11 846 486 | |
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 535 | 36 389 | 4,40 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −798 | 34 854 | −2,24 | 331,76 | −264 744 | 11 563 163 | |
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 697 | 35 652 | 8,18 | ||||
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −756 | 32 955 | −2,24 | 331,76 | −250 811 | 10 933 151 | |
2020-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 735 | 33 711 | 5,43 | ||||
2019-03-19 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 18 045 | 36 198 | 99,41 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Stock Option (Right to Buy) |
M - Exercise | −6 395 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −819 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 663 | 819 | −67,00 | ||||
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −739 | 31 976 | −2,26 | 325,33 | −240 419 | 10 402 752 | |
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −3 370 | 32 715 | −9,34 | 325,33 | −1 096 362 | 10 643 171 | |
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 6 395 | 36 085 | 21,54 | 48,52 | 310 285 | 1 750 844 | |
2019-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 663 | 29 690 | 5,93 | ||||
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 033 | 2 724 | −27,50 | ||||
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 685 | 3 757 | −30,96 | ||||
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −749 | 28 027 | −2,60 | 332,87 | −249 320 | 9 329 347 | |
2019-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 685 | 28 776 | 6,22 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 10 020 | 10 020 | |||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 448 | 6 742 | −17,68 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 920 | 8 190 | −18,99 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 348 | 2 697 | −33,33 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −619 | 27 091 | −2,23 | 319,43 | −197 727 | 8 653 678 | |
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 920 | 27 710 | 7,44 | ||||
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −402 | 25 790 | −1,53 | 319,43 | −128 411 | 8 238 100 | |
2019-02-14 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 348 | 26 192 | 5,43 | ||||
2018-03-20 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 6 708 | 18 153 | 58,61 | ||||
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 091 | 0 | −100,00 | ||||
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −857 | 1 091 | −43,99 | ||||
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −381 | 24 844 | −1,51 | 292,78 | −111 549 | 7 273 826 | |
2018-02-27 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 857 | 25 225 | 3,52 | ||||
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −843 | 2 482 | −25,35 | ||||
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 635 | 3 325 | −32,96 | ||||
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −727 | 24 368 | −2,90 | 284,81 | −207 057 | 6 940 250 | |
2018-02-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 635 | 25 095 | 6,97 | ||||
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 006 | 5 442 | −15,60 | ||||
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 712 | 6 448 | −20,98 | ||||
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −510 | 23 460 | −2,13 | 299,38 | −152 684 | 7 023 455 | |
2018-02-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 712 | 23 970 | 7,69 | ||||
2018-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 10 110 | 10 110 | |||||
2018-02-14 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 4 045 | 4 045 | |||||
2017-07-26 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
S - Sale | X | −4 974 | 22 258 | −18,27 | 290,01 | −1 442 510 | 6 455 043 |
2017-07-20 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
S - Sale | X | −7 758 | 27 232 | −22,17 | 285,00 | −2 211 030 | 7 761 120 |
2017-03-20 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 8 606 | 11 445 | 303,13 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 | 0 | −100,00 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 197 | 1 | −99,95 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 259 | 0 | −100,00 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 375 | 4 960 | −21,70 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −728 | 1 948 | −27,20 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 216 | 2 676 | −31,24 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 103 | 6 335 | −14,83 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 477 | 1 259 | −53,98 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −1 034 | 34 990 | −2,87 | 274,76 | −284 102 | 9 613 852 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 197 | 36 024 | 6,49 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −593 | 33 827 | −1,72 | 274,76 | −162 933 | 9 294 307 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 259 | 34 420 | 3,80 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −447 | 33 161 | −1,33 | 287,63 | −128 571 | 9 538 098 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 375 | 33 608 | 4,27 | ||||
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −335 | 32 233 | −1,03 | 284,75 | −95 391 | 9 178 347 | |
2017-03-02 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 728 | 32 568 | 2,29 | ||||
2017-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 8 160 | 8 160 | |||||
2016-12-02 |
|
4 | IVC |
INVACARE CORP
Common Shares |
A - Award | 2 839 | 2 839 | |||||
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 262 | 3 802 | −24,92 | ||||
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −636 | 5 064 | −11,16 | ||||
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −300 | 31 840 | −0,93 | 258,99 | −77 697 | 8 246 242 | |
2016-02-25 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 636 | 32 140 | 2,02 | ||||
2016-02-24 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
A - Award | 7 270 | 7 270 | |||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
J - Other | −1 521 | 2 674 | −36,26 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 142 | 2 147 | −49,94 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −1 147 | 4 195 | −21,47 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −788 | 31 504 | −2,44 | 247,22 | −194 809 | 7 788 419 | |
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 142 | 32 292 | 7,10 | ||||
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −540 | 30 150 | −1,76 | 247,22 | −133 499 | 7 453 683 | |
2016-02-17 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 1 147 | 30 690 | 3,88 | ||||
2016-02-09 |
|
4 | BIIB |
BIOGEN INC.
Restricted Stock Unit |
M - Exercise | −2 498 | 0 | −100,00 | ||||
2016-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
F - Taxes | −822 | 29 543 | −2,71 | 250,77 | −206 133 | 7 408 498 | |
2016-02-09 |
|
4 | BIIB |
BIOGEN INC.
Common Stock |
M - Exercise | 2 498 | 30 365 | 8,96 | ||||
2015-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 5 700 | 5 700 | |||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
J - Other | −1 041 | 5 342 | −16,31 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −1 627 | 6 383 | −20,31 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 142 | 4 289 | −33,31 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −767 | 27 867 | −2,68 | 392,11 | −300 748 | 10 926 929 | |
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 1 627 | 28 634 | 6,02 | ||||
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 009 | 27 007 | −3,60 | 392,11 | −395 639 | 10 589 715 | |
2015-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 142 | 28 016 | 8,28 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 909 | 0 | −100,00 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 842 | 25 874 | −6,65 | 396,88 | −731 053 | 10 268 873 | |
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 909 | 27 716 | 16,42 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 498 | 2 498 | −50,00 | ||||
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −818 | 23 807 | −3,32 | 402,00 | −328 836 | 9 570 414 | |
2015-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 498 | 24 625 | 11,29 | ||||
2014-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 821 | 0 | −100,00 | ||||
2014-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 803 | 22 127 | −7,53 | 347,11 | −625 839 | 7 680 503 | |
2014-02-25 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 821 | 23 930 | 19,00 | ||||
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 8 010 | 8 010 | |||||
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 142 | 6 431 | −24,99 | ||||
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 010 | 20 109 | −4,78 | 323,04 | −326 270 | 6 496 011 | |
2014-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 142 | 21 119 | 11,29 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 909 | 3 909 | −50,00 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 746 | 18 977 | −8,43 | 315,54 | −550 933 | 5 988 003 | |
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 909 | 20 723 | 23,25 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 498 | 4 996 | −33,33 | ||||
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −819 | 16 814 | −4,64 | 315,54 | −258 427 | 5 305 490 | |
2014-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 498 | 17 633 | 16,50 | ||||
2013-02-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 821 | 3 821 | −50,00 | ||||
2013-02-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 803 | 15 135 | −10,64 | 164,40 | −296 413 | 2 488 194 | |
2013-02-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 821 | 16 938 | 29,13 | ||||
2013-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 8 573 | 8 573 | |||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 909 | 7 818 | −33,33 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 275 | 13 117 | −8,86 | 164,44 | −209 661 | 2 156 959 | |
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 909 | 14 392 | 37,29 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
J - Other | −333 | 7 494 | −4,25 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 165 | 7 827 | −21,67 | ||||
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −702 | 10 483 | −6,28 | 164,44 | −115 437 | 1 723 825 | |
2013-02-12 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 165 | 11 185 | 24,00 | ||||
2012-08-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −1 165 | 9 020 | −11,44 | 142,99 | −166 583 | 1 289 770 |
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −18 750 | 6 250 | −75,00 | |||
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −39 320 | 0 | −100,00 | |||
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −58 070 | 10 185 | −85,08 | 150,00 | −8 710 500 | 1 527 750 |
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 18 750 | 68 255 | 37,87 | 49,65 | 930 938 | 3 388 861 |
2012-07-30 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 39 320 | 49 505 | 386,06 | 60,56 | 2 381 219 | 2 998 023 |
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −29 800 | 0 | −100,00 | |||
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −49 800 | 10 185 | −83,02 | 140,00 | −6 972 000 | 1 425 900 |
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 29 800 | 59 985 | 98,72 | 49,31 | 1 469 438 | 2 957 860 |
2012-06-18 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 20 000 | 30 185 | 196,37 | 45,72 | 914 400 | 1 380 058 |
2012-05-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2012-05-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −20 000 | 10 185 | −66,26 | 135,00 | −2 700 000 | 1 374 975 |
2012-05-03 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 20 000 | 30 185 | 196,37 | 44,73 | 894 600 | 1 350 175 |
2012-04-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −16 764 | 20 000 | −45,60 | |||
2012-04-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −16 764 | 10 185 | −62,21 | 130,00 | −2 179 320 | 1 324 050 |
2012-04-26 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 16 764 | 26 949 | 164,59 | 44,73 | 749 854 | 1 205 429 |
2012-04-06 |
|
4 | BIIB |
BIOGEN IDEC INC.
Stock Option (Right to Buy) |
M - Exercise | X | −3 236 | 36 764 | −8,09 | |||
2012-04-06 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −3 236 | 10 185 | −24,11 | 130,00 | −420 680 | 1 324 050 |
2012-04-06 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | X | 3 236 | 13 421 | 31,77 | 44,73 | 144 746 | 600 321 |
2012-02-28 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −2 117 | 10 185 | −17,21 | 115,43 | −244 365 | 1 175 655 |
2012-02-28 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −2 138 | 12 302 | −14,81 | 115,43 | −246 789 | 1 420 020 |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 307 | 14 440 | −8,30 | 116,39 | −152 122 | 1 680 672 | |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 294 | 15 747 | −7,59 | 116,39 | −150 609 | 1 832 793 | |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −406 | 17 041 | −2,33 | 115,53 | −46 905 | 1 968 747 |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | X | −1 739 | 17 447 | −9,06 | 115,53 | −200 907 | 2 015 652 |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 822 | 7 642 | −33,34 | ||||
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 413 | 19 186 | −6,86 | 116,70 | −164 897 | 2 239 006 | |
2012-02-27 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 822 | 20 599 | 22,78 | ||||
2012-02-14 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
S - Sale | −2 842 | 16 777 | −14,49 | 118,01 | −335 384 | 1 979 854 | |
2012-02-13 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 911 | 11 727 | −25,01 | ||||
2012-02-13 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 257 | 19 619 | −6,02 | 117,78 | −148 049 | 2 310 726 | |
2012-02-13 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 911 | 20 876 | 23,05 | ||||
2012-02-10 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 9 992 | 9 992 | |||||
2011-02-11 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
A - Award | 15 638 | 15 638 | |||||
2010-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 486 | 34 818 | −4,09 | 55,21 | −82 042 | 1 922 302 | |
2010-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 270 | 36 304 | −3,38 | 55,21 | −70 117 | 2 004 344 | |
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −2 666 | 0 | −100,00 | ||||
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −847 | 27 792 | −2,96 | 52,42 | −44 400 | 1 456 857 | |
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 2 666 | 28 639 | 10,26 | ||||
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 217 | 25 973 | −4,48 | 52,61 | −64 026 | 1 366 440 | |
2009-02-17 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 486 | 27 190 | −5,18 | 52,61 | −78 178 | 1 430 466 | |
2008-01-31 |
|
4 | BIIB |
BIOGEN IDEC INC.
Restricted Stock Unit |
M - Exercise | −3 333 | 3 333 | −50,00 | ||||
2008-01-31 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
F - Taxes | −1 129 | 17 716 | −5,99 | 60,00 | −67 740 | 1 062 960 | |
2008-01-31 |
|
4 | BIIB |
BIOGEN IDEC INC.
Common Stock |
M - Exercise | 3 333 | 18 845 | 21,49 |